sacubitril and valsartan sodium hydrate drug combination

an angiotensin II receptor antagonist

Also Known As:

3- (1- biphenyl- 4- ylmethyl- 3- ethoxycarbonyl- 1- butylcarbamoyl)propionate- 3'- methyl- 2'- (pentanoyl(2'- (tetrazol- 5- ylate)biphenyl- 4'- ylmethyl)amino)butyrate; Entresto; LCZ 696; LCZ-696; LCZ696; sacubitril and valsartan drug combination; sacubitril and valsartan sodium anhydrous drug combination; sacubitril valsartan drug combination; sacubitril valsartan sodium anhydrous; sacubitril valsartan sodium hydrate; sacubitril-valsartan; sacubitril-valsartan sodium anhydrous drug combination; sacubitril-valsartan sodium hydrate drug combination; trisodium (3- (1- biphenyl- 4- ylmethyl- 3- ethoxycarbonyl- 1- butylcarbamoyl)propionate- 3'- methyl- 2'- (pentanoyl(2'- (tetrazol- 5- ylate)biphenyl- 4'- ylmethyl)amino)butyrate) hemipentahydrate

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azoles: 2199
    - Tetrazoles: 14
      - Valsartan: 1805
        sacubitril and valsartan sodium hydrate drug combination: 1455
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 31329
  - Branched-Chain Amino Acids: 2371
    - Valine: 2044
      - Valsartan: 1805
        sacubitril and valsartan sodium hydrate drug combination: 1455
  - Aminobutyrates: 1297
    - sacubitril and valsartan sodium hydrate drug combination: 1455
  - Essential Amino Acids: 1179
    - Valine: 2044
      - Valsartan: 1805
        sacubitril and valsartan sodium hydrate drug combination: 1455
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        sacubitril and valsartan sodium hydrate drug combination: 1455
- Carboxylic Acids: 986
  - Acyclic Acids
    - Butyrates: 2742
      - Aminobutyrates: 1297
        sacubitril and valsartan sodium hydrate drug combination: 1455
Pharmaceutical Preparations
- Drug Combinations: 5500
  - sacubitril and valsartan sodium hydrate drug combination: 1455

Jin Shing Hon Selected Research

Jin Shing Hon Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure